A physiologically based pharmacokinetic model for [<sup>68</sup>Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients.
Journal Information
Full Title: EJNMMI Res
Abbreviation: EJNMMI Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Radiology, Nuclear Medicine & Medical Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. The study was approved by the Institutional Review Board (IRB) of the Netherlands Cancer Institute in Amsterdam, the Netherlands (IRBd18078). Consent for publicationNot applicable. Competing interestsAll authors declare that they have no conflict of interest that are relevant to the content of this article. Competing interests All authors declare that they have no conflict of interest that are relevant to the content of this article."
"Funding No funds, grants or other support were received."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025